Attenua, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation Study of Bradanicline in Refractory Chronic Cough (NCT03622216) | Attenua, Inc. | 2018-11-05 |
Track Attenua, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.